As telehealth firms market multi-cancer tests, doctors are wary
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Novo Nordisk says Hims & Hers’ cheaper version of Wegovy pill is illegal
In an unexpected move, Hims & Hers is making available a cheaper, compounded version of the Wegovy weight…
Epic launches AI Charting, scrambling the ambient scribe market
The nation’s largest electronic health record company, Epic Systems, announced on Wednesday more details around its long-anticipated AI…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
UnitedHealth shrinks, Medicare Advantage crackdown: Health Care Inc.
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Senators raise concerns about TrumpRx in letter to HHS watchdog
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
FDA clears AI to detect 14 conditions from CT. What’s next? – statnews.com
FDA clears AI to detect 14 conditions from CT. What’s next? statnews.comFDA clears Aidoc tool to detect 14 different…
Slingshot pulls therapy chatbot Ash out of UK over regulatory concerns
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
We’re reading about Canada speeding drug reviews, Novo ads
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a…
New FDA cell and gene therapy oversight system comes with risks
At a Food and Drug Administration cell and gene therapy (CGT) roundtable last June, most speakers pushed for…